Glaukos (GKOS) EBIT Growth (3y) (2017 - 2026)
Glaukos (GKOS) EBIT Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.33 Bn | 193.73 Bn | 7.27 Bn | 3.16% |
| 2 | Stryker | 126.56 Bn | 123.08 Bn | 4.50 Bn | 19.80% |
| 3 | Medtronic | 118.76 Bn | 109.54 Bn | 6.41 Bn | 6.17% |
| 4 | Boston Scientific | 73.11 Bn | 72.58 Bn | 3.85 Bn | 31.84% |
| 5 | Edwards Lifesciences | 52.09 Bn | 47.84 Bn | 1.35 Bn | 24.88% |
| 6 | Dexcom | 34.43 Bn | 32.48 Bn | 830.00 Mn | 35.44% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 9.04% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 60.19% |
| 9 | Steris | 23.05 Bn | 22.57 Bn | 684.20 Mn | 13.06% |
| 10 | Glaukos | 10.94 Bn | 10.83 Bn | 151.59 Mn | 15.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.94% |
| Mar 31, 2026 | 15.57% |
| Dec 31, 2025 | -60.65% |
| Sep 30, 2025 | 8.85% |
| Jun 30, 2025 | 14.86% |
| Mar 31, 2025 | -60.20% |
| Dec 31, 2024 | -17.06% |
| Sep 30, 2024 | -61.81% |
| Jun 30, 2024 | -28.21% |
| Mar 31, 2024 | -49.02% |
| Dec 31, 2023 | -50.23% |
| Sep 30, 2023 | -31.38% |
| Jun 30, 2023 | 14.91% |
| Mar 31, 2023 | 14.41% |
| Dec 31, 2022 | -4.34% |
| Sep 30, 2022 | -20.29% |
| Jun 30, 2022 | -80.61% |
| Mar 31, 2022 | 91.72% |
| Dec 31, 2021 | -125.19% |
| Sep 30, 2021 | 53.11% |